These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2976766)

  • 21. Advanced glycation end products in diabetic corneas.
    Kaji Y; Usui T; Oshika T; Matsubara M; Yamashita H; Araie M; Murata T; Ishibashi T; Nagai R; Horiuchi S; Amano S
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):362-8. PubMed ID: 10670463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Nov; (11):3-13. PubMed ID: 22312908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
    Cooper ME
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1985 Sep; 34(9):938-41. PubMed ID: 4029512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protein glycation--clinical and chemical aspects].
    Szymańska U; Boratyński J
    Postepy Hig Med Dosw; 1999; 53(5):689-703. PubMed ID: 10645144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells.
    Cavalot F; Anfossi G; Russo I; Mularoni E; Massucco P; Mattiello L; Burzacca S; Hahn AW; Trovati M
    Metabolism; 1996 Mar; 45(3):285-92. PubMed ID: 8606633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications.
    Vlassara H; Brownlee M; Cerami A
    Clin Chem; 1986 Oct; 32(10 Suppl):B37-41. PubMed ID: 3530538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonenzymatic glycation of plasma proteins in smokers.
    Venkatesan A; Hemalatha A; Bobby Z; Selvaraj N; Sathiyapriya V
    Indian J Physiol Pharmacol; 2006; 50(4):403-8. PubMed ID: 17402271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of advanced glycation in the pathogenesis of diabetic retinopathy.
    Stitt AW
    Exp Mol Pathol; 2003 Aug; 75(1):95-108. PubMed ID: 12834631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
    Calvo C
    Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonenzymatic glycosylation and the pathogenesis of diabetic complications.
    Brownlee M; Vlassara H; Cerami A
    Ann Intern Med; 1984 Oct; 101(4):527-37. PubMed ID: 6383165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein glycation and its metabolic consequences.
    Lyons TJ; Jenkins AJ
    Curr Opin Lipidol; 1997 Jun; 8(3):174-80. PubMed ID: 9211066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The unity of image recognition of tolite homothetic receptors and glycosylation end product receptors in biologic function in case of diabetes].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Aug; (8):3-15. PubMed ID: 22164410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pericytes, endothelium monolayer, collagen and elastin chains as the elements of areolar tissue and the substrates of chemical reaction of glyserization].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Jul; (7):3-14. PubMed ID: 21901889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end products and diabetic cardiovascular disease.
    Prasad A; Bekker P; Tsimikas S
    Cardiol Rev; 2012; 20(4):177-83. PubMed ID: 22314141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Effect of diabetes and age.
    Garlick RL; Bunn HF; Spiro RG
    Diabetes; 1988 Aug; 37(8):1144-50. PubMed ID: 3134265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.